Remote Monitoring

VitalSight was designed to help the 37 million Americans who have uncontrolled Stage 2 hypertension and live every day with a higher risk of heart attack and stroke
News | Remote Monitoring
VitalSight in the U.S., Hypertension Plus in the U.K., Recognized as Outstanding Health Technology at CES 2022

February 8, 2022 — OMRON Healthcare, Inc., the global leader in remote blood pressure monitoring and personal health ...

Home February 08, 2022
Home
Abbott plans to expand the monitoring capabilities of its FreeStyle Libre device to enable people to make healthier decisions. The platform uses a disk that is adhered to the skin and uses wireless communication with the patient's smartphone to transfer data into an app where they can monitor their glucose levels in real time without the need for finger prick blood tests. This wearable technology is now being expanded to other areas of biohealth monitoring.
News | Wearables
Abbott Announces Future of Biowearables at Consumer Electronics Show

January 7, 2022 — Abbott announced it is developing a new category of consumer biowearables called Lingo, which is being ...

Home January 07, 2022
Home
FDA clears Implicity algorithm to reduce the volume of false positives from Medtronic implantable loop recorders by nearly 80%
News | Remote Monitoring
FDA Clears AI-Powered ECG Analyzer for Implantable Loop Recorders

January 4, 2022 –  Remote patient monitoring and cardiac data management solutions vendor Implicity received U.S. Food ...

Home January 04, 2022
Home
Patient applying a Cardiac Insight Cardea SOLO monitoring device at home. The remote, physician-prescribed and patient self-applied device is worn for a specified period of monitoring time and then returned to the physician office for report creation. 
Feature | Atrial Fibrillation
Increasing Early Detection of Atrial Fibrillation Through Improved Short-Term Monitoring

Improved short-term monitoring methods for patients with stroke risk can increase early detection of atrial fibrillation ...

Home December 07, 2021
Home
Cardiologs, a leader in artificial intelligence (AI) cardiology diagnostics, announced the results of a clinical study that proved Cardiologs’ deep learning AI outperforms the Apple Watch ECG algorithm in the detection of atrial arrhythmias (AA), which are related to stroke risks. The data was accepted for a moderated digital poster presentation at the American Heart Association (AHA) Scientific Sessions 2021. #AHA ECG Monitoring AI
News | Artificial Intelligence
New Study Shows Cardiologs' Deep Learning AI Outperforms the Apple Watch ECG Algorithm in Detecting Atrial Arrhythmias

November 22, 2021 — Cardiologs, a leader in artificial intelligence (AI) cardiology diagnostics, announced the results ...

Home November 22, 2021
Home
News | Wearables
Novel Algorithm on Wearable Devices Can Detect Irregular Heartbeat, May Prompt Early Care

November 18, 2021 — A novel software algorithm compatible with a wide range of smartwatches and fitness trackers ...

Home November 18, 2021
Home
News | Atrial Fibrillation
Monitoring for Individual Triggers May Reduce Episodes of Atrial Fibrillation

November 17, 2021 — People with atrial fibrillation (AFib) who underwent individualized testing to discover triggers for ...

Home November 17, 2021
Home
The Cardiologs AI-enabled software being used to remotely monitor a cardiac patient. #Telecardiology, cardiac telehealth
News | Remote Monitoring
Philips Expand Cardiac Diagnostics and Monitoring Portfolio With Cardiologs Acquisition

November 20, 2021 – Philips announced it signed an agreement to acquire Cardiologs, a France-based medical technology ...

Home November 09, 2021
Home
The Biotricity Biocare Cardiac app for the Samsung Galaxy Watch4 offers mobile cardiac telemetry with real-time monitoring and transmission of ECG information. It also can interface with FDA-cleared devices, including a digital thermometer, a pulse oximeter and a blood pressure cuff.
News | Wearables
Biotricity Launches Biocare Cardiac Application for Samsung's Galaxy Watch4 Series

October 15, 2021 — Biotricity Inc. announced the release of Biocare Cardiac, a personal, cardiac health application for ...

Home October 15, 2021
Home
SimpleSense is an FDA cleared remote diagnostic platform. The cloth-based nanosensor technology undergarment monitors multiple patient vitals such as heart rate, blood pressure, respiration rate, and physical activity.
News | Cardiac Diagnostics
FDA Clears Nanowear Platform to Implement AI-based Home Diagnostics and Monitoring Network

October 4, 2021 – Nanowear, a hospital-at-home and remote diagnostic platform that used  proprietary wearable cloth ...

Home October 04, 2021
Home
Biotricity Inc., a medical diagnostic and consumer healthcare technology company, has developed a personal medical device kit, Biokit, that includes a bundled of home-use devices to monitor cardiovascular disease. It includes a digital thermometer, a pulse oximeter and a blood pressure cuff. All three devices are U.S. FDA cleared, wireless, wearable, and integrate into the Biotricity ecosystem, a platform for interconnectivity. 
News | Cardiac Diagnostics
Biotricity Releases Biokit With Three Home Monitoring Devices for Cardiac Disease Management

September 28, 2021 — Biotricity Inc., a medical diagnostic and consumer healthcare technology company, has developed a ...

Home September 28, 2021
Home
The Medtronic Linq II implantable cardiac monitor.
News | Atrial Fibrillation
Continuous Heart Rhythm Monitoring and Anticoagulation Does Not Prevent Stroke

September 8, 2021 — Continuous heart rhythm monitoring – with anticoagulation if atrial fibrillation is detected – does ...

Home September 08, 2021
Home
The Medtronic Reveal Linq implantable cardiac monitor (ICM) was used in the SMART-MI study. It is inserted under the skin in a simple, fast outpatient procedure. The device is smaller than a AAA battery.
News | Implantable Cardiac Monitor (ICM)
Implantable Cardiac Monitors Predict Complications in Selected Post-myocardial Infarction Patients

September 7, 2021 — Remote monitoring of implantable cardiac monitors (ICMs) is highly effective for early detection of ...

Home September 07, 2021
Home
A team at the University of South Australia designed a computer vision system that can automatically detect a baby’s face in a hospital bed and remotely monitor its vital signs from a digital camera with the same accuracy as a traditional ECG machine.
News | ECG
Noncontact ECG Monitoring a Step Closer for Neonatal Wards

September 1, 2021 — University of South Australia researchers have designed a computer vision system that can ...

Home September 01, 2021
Home
Gallery | HIMSS | By Dave Fornell, Editor
Photo Gallery of New Technologies at HIMSS 2021

The annual Healthcare Information Management Systems Society (HIMSS) 2021 meeting is the largest health information ...

Home August 18, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now